ClinicalTrials.Veeva

Menu

Anti-Inflammatory Dietary Intervention for Rheumatoid Arthritis (RA-Diet)

A

Attune Health Research

Status

Enrolling

Conditions

Rheumatoid Arthritis

Treatments

Other: Control/Standard of Care
Behavioral: Anti-inflammatory diet

Study type

Interventional

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

The primary objective of this study is to assess if there is a significant difference in the mean disease activity score in individuals with RA participating in a dietary intervention compared to those in the control group measured by DAS-28. Other measures to track disease activity will include monitoring number and severity of disease flares and any changes in medications. This will be done by completing a single-blinded randomized controlled trial, parallel in design. The study population will consist of adults diagnosed with Seropositive and Seronegative RA based on the American College of Rheumatology criteria. Participants will have low, moderate, or high disease activity based on DAS-28 where the investigator feels that they can see improvement from a dietary intervention.

Full description

Per the Schedule of Assessments, upon enrollment, participants will be required to come in for a total of five on site visits. The first visit, also known as the baseline visit, will require participants to provided informed consent after all eligibility criteria is met. Subsequently, participants' Demographics, Medical History, EULAR/ACR classification, and physicians' assessments will be documented. Participants' vital signs will be checked and a thorough physical exam will also be performed after which safety labs will be drawn in addition to a routine urinalysis. Participants will complete outcome surveys and a food frequency questionnaire. Participants' body composition will be measured. Concomitant medications will be reviewed. Each participant will receive nutrition education from an approved MD or a consultation with an approved RD depending on the group to which they have been randomized. Participants who receive consultations with an RD will have seven follow up visits after the baseline visit.

Enrollment

32 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age greater than 18 years.
  • Diagnosed RA by a rheumatologist determined by the 2010 ACR/EULAR Classification Criteria.
  • Low, moderate, or highly active disease state based on clinical assessment where the investigator feels there is potential to see a difference.
  • Able to read and write in English.

Exclusion criteria

  • Younger than 18 years.
  • Unable to attend the 8 weekly nutrition appointment.
  • History of documented eating disorders.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

32 participants in 2 patient groups

Standard of Care (Control Group)
Other group
Description:
Physicians will follow standard of care and instruct participants in the control group to follow a Mediterranean diet higher in vegetables and fruits\[19\]. Patients will be provided with a handout detailing the basics of the Mediterranean diet. At follow up visits, physicians will ask participants about how they have been eating and if they have been following the guidelines.
Treatment:
Other: Control/Standard of Care
Anti-inflammatory Diet (Intervention Group)
Experimental group
Description:
An 8-week nutrition program consisting of an individualized elimination diet and systematic food reintroduction implemented and supervised by a Registered Dietitian. Clinical trials have shown some benefit from elimination diets for individuals with autoimmune disease \[18\]. The specifics of the elimination diet including duration and foods included will be individual and up to the RDs discretion based on the patient's medical and diet history, willingness, current diet, preferences, goals, and ability. The initial diet instruction with a Registered Dietitian will be a one-hour, individual secure video call, with nutrition evaluation/assessment and education on elimination diet protocol. Follow up visits will be approximately 20-30 minutes for the subsequent 7 weeks.
Treatment:
Behavioral: Anti-inflammatory diet

Trial contacts and locations

1

Loading...

Central trial contact

Natalie Fortune, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems